This is a print on demand edition of a hard to find publication. The overall goal of the U.S. National Drug Control Strategy is to reduce illicit drug use in the U.S. U.S.-funded international programs aimed at reducing the supply of drugs have been implemented primarily in drug source countries, such as Colombia and Afghanistan, as well drug transit countries, such as Mexico, Guatemala, and Venezuela. They have included interdiction of maritime drug shipments on the high seas, support for foreign military and civilian institutions engaged in drug eradication, detection, and interdiction; and rule of law assistance aimed at helping foreign legal institutions investigate and prosecute drug trafficking, money laundering, and other drug-related crimes. This statement discusses the author's findings. Illus.
This report is one of several studies conducted by UNODC on organized crime threats around the world. These studies describe what is known about the mechanics of contraband trafficking - the what, who, how, and how much of illicit flows - and discuss their potential impact on governance and development. Their primary role is diagnostic, but they also explore the implications of these findings for policy. Publisher's note.
Mexican drug trafficking organizations (DTOs) pose the greatest crime threat to the United States and have "the greatest drug trafficking influence," according to the annual U.S. Drug Enforcement Administration's (DEA's) National Drug Threat Assessment. These organizations work across the Western Hemisphere and globally. They are involved in extensive money laundering, bribery, gun trafficking, and corruption, and they cause Mexico's homicide rates to spike. They produce and traffic illicit drugs into the United States, including heroin, methamphetamine, marijuana, and powerful synthetic opioids such as fentanyl, and they traffic South American cocaine. Over the past decade, Congress has held numerous hearings addressing violence in Mexico, U.S. counternarcotics assistance, and border security issues. Mexican DTO activities significantly affect the security of both the United States and Mexico. As Mexico's DTOs expanded their control of the opioids market, U.S. overdoses rose sharply to a record level in 2017, with more than half of the 72,000 overdose deaths (47,000) involving opioids. Although preliminary 2018 data indicate a slight decline in overdose deaths, many analysts believe trafficking continues to evolve toward opioids. The major Mexican DTOs, also referred to as transnational criminal organizations (TCOs), have continued to diversify into such crimes as human smuggling and oil theft while increasing their lucrative business in opioid supply. According to the Mexican government's latest estimates, illegally siphoned oil from Mexico's state-owned oil company costs the government about $3 billion annually. Mexico's DTOs have been in constant flux. In 2006, four DTOs were dominant: the Tijuana/Arellano Felix organization (AFO), the Sinaloa Cartel, the Juárez/Vicente Carillo Fuentes Organization (CFO), and the Gulf Cartel. Government operations to eliminate DTO leadership sparked organizational changes, which increased instability among the groups and violence. Over the next dozen years, Mexico's large and comparatively more stable DTOs fragmented, creating at first seven major groups, and then nine, which are briefly described in this report. The DEA has identified those nine organizations as Sinaloa, Los Zetas, Tijuana/AFO, Juárez/CFO, Beltrán Leyva, Gulf, La Familia Michoacana, the Knights Templar, and Cartel Jalisco-New Generation (CJNG). In mid-2019, leader of the long-dominant Sinaloa Cartel, Joaquin ("El Chapo") Guzmán, was sentenced to life in a maximum-security U.S. prison, spurring further fracturing of a once hegemonic DTO. By some accounts, a direct effect of this fragmentation has been escalated levels of violence. Mexico's intentional homicide rate reached new records in 2017 and 2018. In 2019, Mexico's national public security system reported more than 17,000 homicides between January and June, setting a new record. In the last months of 2019, several fragments of formerly cohesive cartels conducted flagrant acts of violence. For some Members of Congress, this situation has increased concern about a policy of returning Central American migrants to cities across the border in Mexico to await their U.S. asylum hearings in areas with some of Mexico's highest homicide rates. Mexican President Andrés Manuel López Obrador, elected in a landslide in July 2018, campaigned on fighting corruption and finding new ways to combat crime, including the drug trade. According to some analysts, challenges for López Obrador since his inauguration include a persistently ad hoc approach to security; the absence of strategic and tactical intelligence concerning an increasingly fragmented, multipolar, and opaque criminal market; and endemic corruption of Mexico's judicial and law enforcement systems. In December 2019, Genero Garcia Luna, a former top security minister under the Felipe Calderón Administration (2006-2012), was arrested in the United States on charges he had taken enormous bribes from the Sinaloa Cartel.
Discusses the strategies and operations of the Drug Enforcement Administration (DEA) in the 1990s. Covers: (1) what major enforcement strategies, programs, initiatives, and approaches DEA has implemented in the 1990s, including its efforts to (a) target and investigate national and international drug traffickers, and (b) help state and local law enforce. agencies combat drug offenders and drug-related initiatives. It includes a recommendation to the Attorney General regarding the development of a measurable DEA performance targets for disrupting and dismantling drug trafficking organizations. Charts and tables.
On Oct. 22, 2007, the U.S. and Mexico announced the Mérida Initiative (MI), a package of U.S. counter-drug and anti-crime assistance for Mexico and Central America that would begin in FY 2008 and last through FY 2010. Contents of this report: (1) Introduction; (2) Development of the MI; (3) Funding the MI: FY 2008-10: Mexico; Central America; The Caribbean; (4) Other MI Legislation in the 111th Congress; (5) Status of Implementation; (6) Policy Issues: Is MI the Right Drug Control Approach?; Monitoring Progress; Interagency Coordination; Role of the DoD; U.S. Pledges Under the MI; Mexico Policy Issues; (7) Beyond the MI: The FY 2011 Request: U.S.-Mexican Security Cooperation. Illustrations.